D. Mouarrawy

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial

M. Beckmann, P. Fasching, T. Fehm, 2017, PloS one.

HER2 expression on circulating tumor cells (CTC) in patients with early HER2-positive breast cancer: Results of the German SUCCESS B trial.

M. Beckmann, A. Schneeweiss, H. Sommer, 2012 .